A Study to Evaluate Folate Receptor Alpha (FRα) Expression in Adult Participants With Ovarian, Fallopian Tube, and Primary Peritoneal Cancer in Italy
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to evaluate the prevalence of folate receptor alpha (FRα)-positive status (≥75% viable tumor cells with moderate (2+) and/or strong (3+) membrane staining) in participants with high-grade serous ovarian, fallopian tube, and primary peritoneal cancer, stratified by time of sampling (initial diagnosis versus relapse), adhering to Ventana folate receptor alpha (FOLR1) RxDx (prescription diagnosis) assay Interpretation Guidance.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Nawrotowy rak jajnika, matek lub otrzewnej
- •Potwierdzona histologicznie wysoko złośliwa postać raka (wysoko zróżnicowany typ ziarenisty)
- •Dostępne próbki tkanek z momentu rozpoznania i pierwszego nawrotu od tego samego pacjenta
- •Próbki z archiwum od stycznia 2016 roku, odpowiednie do przeprowadzenia testu
✗ Disqualifies
- •Niepewne rozpoznanie po ponownym przeanalizowaniu
- •Rozpoznanie oparte tylko na cytologii bez biopsji lub próbki chirurgicznej
- •Inne typy raka niż wysoko złośliwy rak jajnika, matek lub otrzewnej
- •Brak dostępnych próbek tkanek z momentu nawrotu choroby
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 27, 2026
- Sex
- Female only
Locations (1)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Universita Cattolica /ID# 280205
Rome, Italy
Trial contact
Caterina Golotta
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/28/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.